A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes
- 1 October 2000
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 33 (7) , 517-524
- https://doi.org/10.1016/s0009-9120(00)00146-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A NOVEL TEST TO PREDICT SULFONAMIDE HYPERSENSITIVE REACTION IN NORMAL POPULATION AND IN IMMUNOCOMPROMISE SUBJECTSTherapeutic Drug Monitoring, 1999
- CYP2E1 inducers modulate valproic acid toxicity and induces 4-ene-valproic acid apoptosis in Hep G2 cellsJournal of Hepatology, 1998
- Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell lineGastroenterology, 1995
- Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsantsArchives of Dermatology, 1995
- Acetaminophen-lnduced Toxicity to Human Epidermoid Cell Line A431 and Hepatoblastoma Cell Line Hep G2, in vitro. Is Diminished by SilymarinSkin Pharmacology and Physiology, 1995
- In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIVClinical and Experimental Immunology, 1993
- Glutathione deficiency and human immunodeficiency virus infectionThe Lancet, 1992
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.Journal of Clinical Investigation, 1988
- Genetic susceptibility to toxic epidermal necrolysisArchives of Dermatology, 1987
- In vitro evaluation of a toxic metabolite of sulfadiazineCanadian Journal of Physiology and Pharmacology, 1985